Title : Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates - Hackett_2005_Hum.Gene.Ther_16_1484 |
Author(s) :
Hackett NR , Redmond DE , Sondhi D , Giannaris EL , Vassallo E , Stratton J , Qiu J , Kaminsky SM , Lesser ML , Fisch GS , Rouselle SD , Crystal RG |
Ref :
Hum Gene Therapy , 16 :1484 , 2005 |
Abstract : Hackett_2005_Hum.Gene.Ther_16_1484 |
ESTHER : Hackett_2005_Hum.Gene.Ther_16_1484 |
PubMedSearch : Hackett_2005_Hum.Gene.Ther_16_1484 |
PubMedID: 16390279 |